Status:
RECRUITING
Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Mild Cognitive Impairment (MCI)
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinking® (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI)....
Eligibility Criteria
Inclusion
- Inclusion criteria:
- self-identify as Chinese American;
- age 55 and above;
- a diagnosis of MCI as confirmed through documented clinical assessment and/or research-based diagnostic criteria;
- predominantly Cantonese- or Mandarin-speaking;
- able to read and write in Chinese;
- visual and auditory acuity adequate for cognitive testing;
- willing to complete the assessment measures;
- having someone in regular contact to serve as a study partner/informant;
- absence or stable use of prescribed memory-enhancing medications within the last 3 months.
- Exclusion criteria include:
- any significant neurologic disease that would impact their participation and completion of the trial;
- history of psychiatry disorder (DSM 5 criteria) within the last 12 months;
- history of reading or writing disability sufficient to interfere with MSS training; or
- concurrent participation in another relevant clinical trial.
Exclusion
Key Trial Info
Start Date :
July 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT07142499
Start Date
July 29 2025
End Date
May 1 2026
Last Update
November 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Li Lab, Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029